Universe Pharmaceuticals Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a UPC research report →
Price Chart
About the company
Universe Pharmaceuticals Inc. (UPC) operates as a pharmaceutical enterprise primarily focused on the Chinese market. The company specializes in the production, promotion, and sale of products derived from traditional Chinese medicine (TCM).
- CEO
- Gang Lai
- IPO
- 2021
- Employees
- 216
- HQ
- Ji'An, JX, CN
Get TickerSpark's AI analysis on UPC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $682.30K
- P/E
- -0.39
- PEG
- 0.00
- P/S
- 0.05
- P/B
- 0.01
- EV/EBITDA
- 13.14
- Div Yield
- 0.00%
- Gross Margin
- 35.86%
- Op Margin
- -11.78%
- Net Margin
- -10.95%
- ROE
- -3.48%
- ROIC
- -3.20%
Latest fiscal year · YoY change
- Revenue
- $17.86M-22.4%
- Gross Profit
- $6.30M+3.8%
- Op Income
- $-2,915,919
- Net Income
- $-3,672,055+57.9%
- EPS
- $-1055.75+26.5%
- OCF Growth
- +46.9%
- FCF Growth
- +45.3%
- 52W High
- $17.96
- 52W Low
- $1.05
- 50D MA
- $3.27
- 200D MA
- $3.61
- Beta
- 1.85
- RSI (14)
- 23
- Avg Volume
- 176.76K
No earnings-call transcripts are available for UPC yet.
- Free Float
- 77.1%
- Shares Outstanding
- 631.76K
- Float Shares
- 487.25K
of shares held by institutions
4 13F filers
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Geode Capital Management, LLC | 44.53K | ▲ 44.53K |
| Citadel Advisors LLC | 14.63K | ▲ 14.63K |
| Jane Street Group, LLC | 11.29K | ▲ 11.29K |
| Osaic Holdings, Inc. | 6.17K | 0 |
| Ubs Group AG | 1.55K | ▼ 12.82K |
| National Bank Of Canada | 1 | ▲ 1 |
| Caitong International Asset Management Co., Ltd | 1 | ▼ 11 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 7, 26 | Lai Gang | other | 71,890 |
| May 7, 26 | Lai Gang | other | 12,610 |
| Mar 18, 26 | Zheng Ding | other | 0 |
| Mar 18, 26 | Lai Gang | other | 0 |
| Mar 18, 26 | Liu Baochang | other | 0 |
| Mar 18, 26 | Pang Jiawen | other | 0 |
| Mar 18, 26 | Yang Lin (Lydia) | other | 0 |
| Mar 18, 26 | Yu Yongping | other | 0 |
| Jun 30, 04 | HARTON LYNN | other | 4,700 |
| Jun 30, 04 | HARTON LYNN | other | 43 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our UPC coverage
Recent articles, reports, and earnings notes.
No research on UPC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate UPC report →Universe Pharmaceuticals (NASDAQ:UPC) Share Price Breaks Below Two Hundred Day Moving Average – Here’s Why
defenseworld.net · Oct 27
Law Offices of Howard G. Smith Announces Investigation of Universe Pharmaceuticals INC.
businesswire.com · Oct 12
The Law Offices of Frank R. Cruz Announces Investigation of Universe Pharmaceuticals INC.
businesswire.com · Oct 7
Universe Pharmaceuticals INC (NASDAQ:UPC) Stock Short Interest Rises 154.7%
defenseworld.net · Sep 29
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
globenewswire.com · Jun 26
Universe Pharmaceuticals INC Announces Strategic Acquisition to Expand Pharmaceutical Patent Portfolio
globenewswire.com · Jun 26
Hologic Secures Significant Patent Victory Against Siemens Over Breast Cancer Detection Technology
businesswire.com · Jun 16
Universe Pharmaceuticals (NASDAQ:UPC) Stock Price Down 2.4% – Time to Sell?
defenseworld.net · Apr 25
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.